STERIS Files Quarterly 10-Q Report with SEC

The healthcare sterilization and life sciences equipment provider submitted its latest quarterly disclosure to regulators.

STE · 2026-08-08 · MarginX

Routine Regulatory Filing

STERIS plc filed its quarterly report on Form 10-Q with the Securities and Exchange Commission on August 7, according to SEC EDGAR records. The filing represents the company's routine disclosure obligations for publicly traded firms operating in the healthcare equipment sector.

The healthcare sterilization and life sciences equipment provider, with a market capitalization of approximately $23 billion, closed at $237.47 per share prior to the filing. The company serves hospitals, pharmaceutical manufacturers, and medical device companies with infection prevention and contamination control products.

Recent Corporate Activity

According to MarginX data, the company has seen recent insider activity involving executive Mohsen Sohi, who exercised options totaling 3,781 shares on two separate occasions. In connection with one of these transactions, 1,837 shares were withheld for tax purposes, a standard practice when executives exercise stock options.

The insider transactions represent routine activity often associated with executive compensation structures and do not necessarily indicate sentiment about the company's future prospects.

Looking Ahead

STERIS shareholders can expect a quarterly dividend payment of $0.69 per share on September 4, 2026, according to MarginX data. The company maintains a regular dividend policy as part of its capital allocation strategy.

Investors will receive the company's next quarterly earnings report on November 4, 2026, when STERIS is expected to announce its second quarter fiscal 2027 results. That announcement will follow two Federal Open Market Committee meetings scheduled for September 16 and October 28, which may influence broader market conditions and healthcare sector performance.

The 10-Q filing provides detailed financial information, management discussion and analysis, and disclosure of material events for the reporting period, offering investors and analysts insight into the company's operational and financial performance during the quarter.

This article was generated by MarginX from public news on 2026-08-07. It is not investment advice.

Go deeper on STE — scores, valuation multiples, filings and earnings-call search on MarginX.